In conclusion, Our results suggest that LbGP can be used as an alternative drug to inhibit glioma proliferation, we speculate that LbGP suppresses the expression of SREBP1c by up-regulating Per2, thus inhibiting lipid synthesis and metabolism in gliomas. Here, SREBF1 is linked to central nervous system cancer.